Pfizer Announces Acquisition Of Top Chinese Healthcare Brand, Considering Sale Of Hospira Pump Unit

Pfizer Inc.PFEannounced on Wednesday that it has acquired Sirio Pharma Co's wholly-owned subsidiary, Treerly Health Co. Treerly is a top healthcare brand in China's retail channel. As part of the deal, Pfizer has acquired the entire family of Treerly products which are "uniquely designed to meet women's nutritional healthcare needs throughout their lives." Pfizer added that the acquisition "compliments" its already existing consumer healthcare product portfolio. Terms of the deal were not initially announced. Separately, Bloomberg reported that Pfizer is considering a sale of the pumps and devices business that was part of its acquisition of Hospira. Bloomberg, citing "people with knowledge of the matter," noted that Pfizer could receive about $2 billion from a potential sale although the sales process is at a "very early stage." Shares of Pfizer were trading higher by 0.26 percent at $30.45 30 minutes after Thursday's market open.